iifl-logo

Ajanta Pharma Ltd Board Meeting

2,523.2
(-1.01%)
Nov 14, 2025|12:00:00 AM

Ajanta Pharma CORPORATE ACTIONS

15/11/2024calendar-icon
15/11/2025calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting3 Nov 20258 Oct 2025
Ajanta Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2025 inter alia to consider and approve Unaudited consolidated and standalone financial results for the second quarter and half year ended 30th September 2025 PFA Board Meeting Outcome (As Per BSE Announcement Dated on: 03.11.2025)
Board Meeting28 Jul 202516 Jul 2025
Ajanta Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2025 inter alia to consider and approve Unaudited financial results for the quarter ended 30.06.2025. PFA Unaudited Financial Results for quarter ended 30.06.2025. (As Per BSE Announcement Dated on: 28/07/2025)
Board Meeting30 Apr 202522 Apr 2025
Ajanta Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2025 inter alia to consider and approve Audited Financial results for the quarter and year ended 31st March 2025 PFA Audited Results Outcome of the Board Meeting PFA Intimation w.r.t re-appointment of Mr. Madhusudan Agrawal. (As Per BSE Announcement Dated on 30.04.2025)
Board Meeting30 Jan 202517 Jan 2025
AJANTA PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2025 ,inter alia, to consider and approve Unaudited consolidated & standalone financial results of the Company for the third quarter and nine months ended 31st December 2024 PFA Results of 31st Dec 2024. (As per BSE Announcement Dated on 30/01/2025)

Ajanta Pharma: Related News

Ajanta Pharma Q4 Profit Rises 11% to ₹225 Crore

Ajanta Pharma reported a strong EBITDA margin of 25% in the quarter.

30 Apr 2025|04:50 PM
Read More
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.